Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex.
A mycobacterial cell wall complex prepared from the non-pathogenic microorganism Mycobacterium phlei, where mycobacterial DNA is preserved and complexed to cell wall fragments, possesses anticancer and immunomodulatory activity. DNA from a number of prokaryotes has been found to modulate the immune system and to induce cytokine synthesis. We have therefore determined whether the DNA associated with this complex has the ability to induce the synthesis of interleukin-12 (IL-12), a potent anticancer cytokine. Mycobacterial DNA complexed with cell wall fragments or DNA purified from M. phlei induced IL-12 synthesis by murine and human monocytes and macrophages in vitro, and was capable of inducing IL-12 synthesis in vivo in mice following i.p. administration. Neutralization of DNA with cationic liposomes or digestion with DNase I significantly decreased the ability of the cell wall complex to induce IL-12. CpG methylation of DNA extracted from these cell walls or from M. phlei did not affect the induction of IL-12 synthesis by monocytes and macrophages. In contrast, CpG methylation of DNA from Escherichia coli abolished its ability to induce IL-12 synthesis. These results demonstrate that unmethylated CpG motifs present in M. phlei DNA are not a prerequisite for the induction of IL-12 synthesis. The size of the mycobacterial DNA, in the range of 5 bp to genomic DNA, did not influence its capacity to induce IL-12. Our results emphasize that M. phlei DNA associated with the cell wall complex makes a significant contribution to the overall immunomodulatory and anticancer activity of this mycobacterial cell wall preparation and that these activities are not correlated with the presence of CpG motifs.
Filion
M C
MC
Bioniche Therapeutics Research Centre, Montréal, Québec, Canada. mario.filion@nrc.ca
Filion
B
B
Reader
S
S
Ménard
S
S
Phillips
N C
NC
D000818:Animals; D002473:Cell Wall / Q000737:chemistry*; D019175:DNA Methylation; D004269:DNA, Bacterial / Q000494:pharmacology*; D015226:Dinucleoside Phosphates / Q000502:physiology*; D005260:Female; D018922:HL-60 Cells; D006801:Humans; D018664:Interleukin-12 / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000032:analysis; D008081:Liposomes / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009168:Mycobacterium phlei / Q000502:physiology*; D009171:Mycolic Acids / Q000494:pharmacology
D004269:DNA, Bacterial; D015226:Dinucleoside Phosphates; D018664:Interleukin-12; D008070:Lipopolysaccharides; D008081:Liposomes; D009171:Mycolic Acids; C015772:CpG dinucleotide